| Literature DB >> 27760188 |
Camila Henriques Coelho1, Adriana Oliveira Costa1, Ana Carolina Carvalho Silva1, Maíra Mazzoni Pucci2, Angela Vieira Serufo1, Haendel Goncalves Nogueira Oliveira Busatti1, Maurício Durigan3, Jonas Perales4, Alex Chapeaurouge4, Daniel Almeida da Silva E Silva5, Maria Aparecida Gomes6, Juliano Simões Toledo1, Steven M Singer7, Rosiane A Silva-Pereira2, Ana Paula Fernandes1.
Abstract
The zoonotic potential of giardiasis, as proposed by WHO since the late 70's, has been largely confirmed in this century. The genetic assemblages A and B of Giardia duodenalis are frequently isolated from human and canine hosts. Most of the assemblage A strains are not infective to adult mice, which can limit the range of studies regarding to biology of G. duodenalis, including virulence factors and the interaction with host immune system. This study aimed to determine the infectivity in mice of an assemblage A Giardia duodenalis strain (BHFC1) isolated from a dog and to classify the strain in sub-assemblages (AI, AII, AIII) through the phylogenetic analysis of beta-giardin (bg), triose phosphate isomerase (tpi) and glutamate dehydrogenase (gdh) genes. In addition, the proteomic profile of soluble and insoluble protein fractions of trophozoites was analyzed by 2D-electrophoresis. Accordingly, trophozoites of BHFC1 were highly infective to Swiss mice. The phylogenetic analysis of tpi and gdh revealed that BHFC1 clustered to sub-assemblage AI. The proteomic map of soluble and insoluble protein fractions led to the identification of 187 proteins of G. duodenalis, 27 of them corresponding to hypothetical proteins. Considering both soluble and soluble fractions, the vast majority of the identified proteins (n = 82) were classified as metabolic proteins, mainly associated with carbon and lipid metabolism, including 53 proteins with catalytic activity. Some of the identified proteins correspond to antigens while others can be correlated with virulence. Besides a significant complementation to the proteomic data of G. duodenalis, these data provide an important source of information for future studies on various aspects of the biology of this parasite, such as virulence factors and host and pathogen interactions.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27760188 PMCID: PMC5070761 DOI: 10.1371/journal.pone.0164946
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Consensus phylogenetic relationships of G. duodenalis with Bayesian posterior probabilities using a Markov chain Monte Carlo sampling technique, for bg, tpi, and gdh gene sequences of G. duodenalis.
Markov chains were run for 6,000,000 iterations and the trees were sampled every 100 iterations. The GTR model was used with gamma correction. Sequences from Giardia muris, Giardia microti and Giardia ardeae were employed as outgroups.
Number of trophozoites or cysts recovered from Swiss mice gut after infection with G. duodenalis strains BHCF1 and Portland-1.
Mice were inoculated with 1 x 106 trophozoites through intra-gastric route. Parasites were recovered from gut and counted in Neubauer chamber. Numbers correspond to average and standard deviation of parasite counting’s obtained for each group, from three independent experiments, with minimal number of 3 mice per group, in each experiment.
| Strain | Mean and Standard Deviation of parasite counts | ||
|---|---|---|---|
| Experiment 1 (n = 3) | Experiment 2(n = 4) | Experiment 3 (n = 4) | |
| 29,167 ± 21,262 | 135,000 ±112,110 | 121,667±98,752 | |
| 500 ± 866.02 | 333.33±577.35 | 0±0 | |
a Only trophozoites were recovered
b Only cysts were recovered
Fig 22D protein map showing the spots of the soluble protein fraction (Proteins 1 to 429) and the numerical distribution of localized proteins.
The protein identification correspondent to each number is shown in S3 Table.
Fig 32D protein map showing the spots of the insoluble fraction (Proteins 430 to 903) and the numerical distribution of localized proteins.
The protein identification correspondent to each number is shown in S3 Table.
Characteristics of the identified hypothetical proteins, including the access number, the number of amino acids (aa) and the presence of putative conserved domains according to Protein Blast webtool (http://blast.ncbi.nlm.nih.gov).
| ORF number | Number of amino acids | Conserved domains |
|---|---|---|
| GL50803_10016 | 317 | Fascin Superfamily |
| GL50803_10524 | 250 | Absent |
| GL50803_10808 | 228 | Absent |
| GL50803_10524 | 837 | Absent |
| GL50803_115159 | 644 | Phospholipase B |
| GL50803_12224 | 300 | Smc (Structural maintenance of chromosomes) |
| GL50803_13584 | 386 | Smc |
| GL50803_21628 | 184 | Absent |
| GL50803_15499 | 431 | Sm (Archae type) |
| GL50803_15918 | 228 | Absent |
| GL50803_16267 | 537 | Trichoplein |
| GL50803_16424 | 252 | Mlf1IP (Myelodysplasia-myeloid leukemia factor 1-interacting protein) |
| GL50803_16507 | 875 | Absent |
| GL50803_16844 | 324 | Absent |
| GL50803_16996 | 413 | Enkurin (Calmodulin-binding) |
| GL50803_17278 | 297 | Absent |
| GL50803_2107 | 328 | Absent |
| GLC50803_21628 | 383 | Absent |
| GL50803_24451 | 139 | FGF family (Fibroblast growth factors) |
| GL50803_3910 | 123 | TRX Family |
| GL50803_4149 | 440 | Hom_end_hint |
| GL50803_4239 | 98 | Absent |
| GL50803_4692 | 239 | Absent |
| GL50803_5810 | 131 | Pyridoxine 5'-phosphate(PNPOx-like) |
| GL50803_19861 | 385 | Absent |
| GLP15_2507 | 821 | Absent |
| GL50803_115159 | 644 | Phospholipase B |
Fig 4Classification of the identified proteins by molecular function (A), biological process (B) and protein class (C).
This classification is suggested by gene ontology and Panther® and provides a general characterization of a group of proteins. The numbers presented in each graph correspond to the number of proteins.
Presence of transmembrane domains and signal peptide for the annoted proteins identified in insoluble and soluble protein fractions.
| Protein Description | ORF name | TD | SP | Insoluble fraction | Soluble fraction |
|---|---|---|---|---|---|
| Cathepsin L precursor | GL50803_16380 | X | X | ||
| Variant-Specific Surface Protein 160 (VSP-160) | GL50803_137612 | X | X | X | |
| Cathepsin B precursor | GL50803_14019 | X | X | ||
| Tenascin-like | GL50803_16833 | X | X | ||
| Thymus-specific serine protease precursor | GL50803_10843 | X | X | ||
| Adenylate kinase | GL50803_90402 | X | X | ||
| PDI5—Protein disulfide isomerase | GL50803_8064 | X | X | X | |
| Variant-Specific Surface Protein 126.1 (VSP-126.1) | GL50803_11521 | X | X | X | |
| Leucine-rich repeat protein | GL50803_4039 | X | X | X | |
| Leucine-rich repeat protein 1 virus receptor protein | GL50803_5795 | X | X | X | |
| Variant-Specific Surface Protein 100 (VSP-100) | GL50803_33279 | X | X | X | |
| Serine peptidase, putative | GL50803_15871 | X | X | ||
| Variant-Specific Surface Protein 88 (VSP-88) | GL50803_101074 | X | X | X | |
| Leucine-rich repeat protein | GL50803_5795 | X | X | ||
| Alanyl dipeptidyl peptidase | GL50803_15574 | X | X | X | |
| High cysteine membrane protein Group 1 | GL50803_15317 | X | X | X | |
| Bip (BiP) | GL50803_17121 | X | X | X | |
| Dipeptidyl-peptidase I precursor | GL50803_8741 | X | X | X | |
| Peptidyl-prolyl cis-trans isomerase B precursor | GL50803_17000 | X | X | ||
| Tenascin precursor | GL50803_8687 | X | X | ||
| Alpha-7.2 giardin | GL50803_114119 | X | X | ||
| Variant-Specific Surface Protein 186 (VSP-186) | GL50803_14586 | X | X | X | |
| Phospholipase B | GL50803_93548 | X | X | ||
| Neurogenic locus Notch protein precursor | GL50803_16322 | X | X | ||
| 5' nucleotidase family protein | GL50803_92645 | X | X | ||
| Lysosomal acid phosphatase precursor | GL50803_7556 | X | X | ||
| High cysteine membrane protein Group 2 | GL50803_16721 | X | X | ||
| Variant-Specific Surface Protein 71 (VSP-71) | GL50803_137681 | X | X | ||
| Variant-Specific Surface Protein 53.1 (VSP-53.1) | GL50803_11470 | X | X |